FF
EBS icon

FourThought Financial’s Emergent Biosolutions EBS Stock Holding History

FourThought Financial’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
40
– – ﹤0.01% 1399
2022
Q2 		$1K Hold
40
– – ﹤0.01% 1393
2022
Q1 		$2K Buy
+40
New +$1.76K ﹤0.01% 1333
2021
Q4 		– Sell
-1,264
Closed -$63K – 1504
2021
Q3 		$63K Sell
1,264
-36,724
-97% -$2.22M 0.01% 621
2021
Q2 		$2.39M Buy
37,988
+28,874
+317% +$1.85M 0.32% 67
2021
Q1 		$846K Buy
9,114
+448
+5% +$45.9K 0.12% 138
2020
Q4 		$776K Buy
+8,666
New +$795K 0.12% 132

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FourThought Financial's EBS Position: Q3 2022 in Review

FourThought Financial held its Emergent Biosolutions (EBS) position steady in Q3 2022 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

FourThought Financial first reported a position in EBS in Q4 2020 and has held it in 7 quarters since. The position peaked at $2.39M in Q2 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • FourThought Financial held 40 shares of Emergent Biosolutions worth $1K as of Q3 2022.
  • FourThought Financial left its Emergent Biosolutions share count unchanged in Q3 2022.
  • Emergent Biosolutions made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1399 holding.
  • FourThought Financial first reported a position in Emergent Biosolutions in Q4 2020 and has held it in 7 quarters since.
  • FourThought Financial's Emergent Biosolutions position peaked at $2.39M in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.